Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 29, 2003Journal of Clinical Oncology

Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAlex A. AdjeiCleveland ClinicAMAnn M. MauerCentre for the Observation and Modelling of Earthquakes, Volcanoes and TectonicsLBLaura M. BruzekMayo Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Adjei et al. (2003) studied this question.

synapsesocial.com/papers/6aa8aca572f784a6546bf8e5https://doi.org/10.1200/jco.2003.09.075
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Current status of clinical trials of farnesyltransferase inhibitors2001 · 112 citations
  2. 2The gamma subunit of transducin is farnesylated.1990 · 188 citations
  3. 3The Phosphoinositide 3-OH Kinase/AKT2 Pathway as a Critical Target for Farnesyltransferase Inhibitor-Induced Apoptosis2000 · 241 citations